Sirona Dental Systems (XRAY): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Dentsply (XRAY)

DENTSPLY SIRONA Inc. (XRAY) dominates through its CAD/CAM digital ecosystem, which creates high dependency for clinics. The foundation of its success lies in a staff of elite materials scientists and a closed B2B cycle driven by consumables. The company's P/S ratio clearly demonstrates these trends, with the 0.50 level serving as a critical benchmark. Analyzing this indicator allows investors to filter out market noise and determine an optimal entry point.

Price-to-Revenue Ratio: Dentsply Sirona (XRAY) for 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Dentsply Sirona (XRAY)

- stock quotes and analyst forecast:
Summary company analytics:Dentsply Sirona Inc
Mass-produced product of dentsplysirona.com

An investment audit of DENTSPLY SIRONA Inc. (XRAY) requires an analysis of the ratio of the business's market value to its annual turnover. The company's P/S ratio determines the market valuation of each unit of revenue, which is critical for assessing the efficiency of its network of high-tech dental equipment manufacturing plants. The P/S ratio trend allows for a comparison of the issuer's capitalization with the actual operational stability of its production capacities in the US and EU.

Competitors of DENTSPLY SIRONA Inc.

Market Cap to Sales Volume ISRG|Danaher Corporation - Market Cap to Revenue|P/S Multiple Becton Dickinson & Company BDX|STE - Price-to-Revenue Ratio|West Pharmaceutical Services (WST) - Market Cap to Revenue|BAX: P/S Multiple|Market Cap to Revenue Masimo|STVN (stevanatogroup.com) - P/S Multiple|Market Cap to Revenue Ratio TFX (Teleflex Incorporated)|Price-to-Revenue Ratio Merit Medical (MMSI)|Envista - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume LMAT (LeMaitre Vascular Inc)|ATRC - Price-to-Revenue Ratio|Price-to-Revenue Coefficient STAAR Surgical Co STAA|NAGE: P/S Multiple|Price-to-Sales Ratio ZIMV (ZimVie Inc.)|Price-to-Revenue Ratio AngioDynamics Corp|Price to Sales Cerus Corp. CERS|Price-to-Revenue Ratio Teknova (TKNO)|Monogram Orthopedics Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Sharps Technology, Inc. STSS|P/S Multiple InfuSystem Holdings INFU|UTMD: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio KRMD (KORU Medical)|NYXH: P/S Multiple|MBOT (Microbot Medical, Inc) - Price-to-Revenue Ratio|Market Cap to Revenue PDEX|ZTEK: Market Capitalization-to-Revenue Ratio|P/S Multiple ELUT|Milestone Scientific Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NEXGEL, Inc. NXGL|Retractable Tech - Price-to-Revenue Ratio|harvardbioscience.com - P/S Multiple|FEMY (Femasys Inc.) - Market Cap to Revenue Ratio|MHUA: P/S Multiple|Predictive Oncology Corp - Market Capitalization-to-Revenue Ratio|CJMB (Callan JMB) - P/S Multiple|Price to Sales Atrion Corporation Inc. ATRI|P/S Multiple NURO